Kazia Therapeutics LTD insider trading

Every open-market purchase and sale by Kazia Therapeutics LTD's officers, directors and largest shareholders since November 4, 2021, and what the share price did next.

No open-market insider trades reported in the last five years.

Does following Kazia Therapeutics LTD’s insiders pay?

From February 27, 2013 to November 6, 2013, 1 insider reported 0 open-market purchases and 4 sales not made under a pre-set plan in Kazia Therapeutics LTD. After sales, the shares moved −61.9% against the index over 12 months (a negative figure means selling was the right call).

Kazia Therapeutics LTD: each insider's record
Insider	Role	Purchases	12 months after their purchases	Beat the S&P 500	Sales	12 months after their sales	Latest report
Austin Josiah T	10% owner	0	—	—	4	−61.9% (3)	November 6, 2013

Moves are the shares’ return including dividends minus the S&P 500’s, from the close on the first trading day after each report; the number of trades with a finished 12-month window is in brackets. Green means the trade went the insider’s way (a purchase ahead of the index, a sale followed by the shares trailing it). A trade reported both by a director or officer and by a fund or company they are linked to counts once here, under the person. Purchases count only where the share price actually traded was at least $5. These figures describe what the shares did, not why anyone traded. Insiders across all companies.

← Back to Kazia Therapeutics LTD · Funds · Politicians